The Official CORMEDIX (CRMD)thread (run up to FDA approval has begun )

[KING WILL]

hmm, i'd have to read through that study thoroughly, but at face value, it's hard for me to say there's a correlation between statins and development of DM (diabetes). Alot of people w/ DM will end up with lipid issues and vice versa. Is there a true correlation with statin use or is it just the natural progression of someone already at risk? seems fishy to me, but again i'd have to read more on it. and statins aren't for lowering lower blood pressure.

Very possible, if you come across anything else, lmk.

 

[KING WILL]

Amarin (NASDAQ:AMRN) received a $51.00 price target from stock analysts at HC Wainwright in a report issued on Wednesday, TipRanks reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. HC Wainwright’s target price would indicate a potential upside of 178.84% from the company’s current price.

Amarin (NASDAQ:AMRN) Given a $51.00 Price Target by HC Wainwright Analysts

 

[KING WILL]

The detailed analysis of health records and other data from patients in a private insurance plan in the Midwest provides a real-world picture of how efforts to reduce heart disease may be contributing to another major medical concern, said Victoria Zigmont, who led the study as a graduate student in public health at The Ohio State University.

Statins are a class of drugs that can lower cholesterol and blood pressure, reducing the risk of heart attack and stroke. More than a quarter of middle-aged adults use a cholesterol-lowering drug, according to recent federal estimates.

Researchers found that statin users had more than double the risk of a diabetes diagnosis compared to those who didn't take the drugs. Those who took the cholesterol-lowering drugs for more than two years had more than three times the risk of diabetes.

https://medicalxpress.com/news/2019...&utm_medium=email&utm_campaign=daily-nwletter


@funkee

What you think of this?

In 1996, the U.S. Food and Drug Administration (FDA) approved Lipitor for the purpose of lowering cholesterol. Following its release, researchers found that more people who are on statin therapy are diagnosed with type 2 diabetes compared to people who are not on statin therapy.


Does Lipitor Increase My Risk for Diabetes?


WEDNESDAY, March 4, 2015 (HealthDay News) -- Cholesterol-lowering statin drugs may significantly increase a person's risk of developing type 2 diabetes, a new study from Finland suggests.

Researchers found that statins were associated with an almost 50 percent higher risk of developing type 2 diabetes, even after adjusting for other factors.

Statins appear to increase the risk of type 2 diabetes in several ways, the researchers said. One is that the drugs can increase a person's insulin resistance, and the other is that the cholesterol-lowering drugs seem to impair the ability of the pancreas to secrete insulin, according to the report.


Statins Linked to Raised Risk of Type 2 Diabetes



One of the world's most widely used drugs, statins have been hailed by the medical community for their ability to prevent heart disease.

Still, the researchers, who have published their findings in the journal Diabetes, were confused as to why diabetes was linked to statin use.

"Recently, an increased risk of diabetes has been added to the warning label for statin use," says lead author Jonathan Schertzer, assistant professor of Biochemistry and Biomedical Sciences, and Canadian Diabetes Association Scholar.

"This was perplexing to us," he continues, "because if you are improving your metabolic profile with statins you should actually be decreasing the incidence of diabetes with these drugs, yet, the opposite happened."



Study uncovers why statins increase diabetes risk and offers solution

 

[newarkhiphop]

up almost 9% right now

 

[ahomeplateslugger]

CRMD up 17% today

 

[Tug life]

Today's volume and price action is the result of being added to the Russell 2000. Not sure how the price will hold going forward, but this is one of the reasons they did a reverse split, to be able to be seen and acquired by more shareholders and institutions. I just cant wait until the drop the news we've all been waiting for

 

[newarkhiphop]

Today's volume and price action is the result of being added to the Russell 2000. Not sure how the price will hold going forward, but this is one of the reasons they did a reverse split, to be able to be seen and acquired by more shareholders and institutions. I just cant wait until the drop the news we've all been waiting for

I keep seeing rumors they might be bought out, any truth to that? would that be good?

 

[Tug life]

I keep seeing rumors they might be bought out, any truth to that? would that be good?

They will either partner with a big pharma company or they will be bought out, one of the two will happen if Neutrolin is as successful as expected. Management has made is very clear they are willing to partner, we know with their current financial situation and being a very small company they cannot successfully take Neutrolin to market alone. They only thing is either of the two will take a little while. If we get approved for NDA, a partnership will probably follow but a buyout will be after FDA approval which will likely come in 1st quarter 2020. They said in one of the conference calls, and its listed on their website that if they get FDA approval they will be ready to hit the market the second half of next year.

A buyout will be good but it all depends on the price action. Companies usually pay a premium for the businesses they want to acquire. Most of the time 100% or more and the higher the price at the time of the buyout the higher the payout. Also if the share price spikes to lets say $50 then settled at $20 on FDA approval and someone held for a buyout but the buyout price is only $35. It all depends on your exit strategy and how many billions the are willing to pay

 

[KING WILL]

Congrats to yall boys!!!

 

[thaKEAF]

 

[broller]

They will either partner with a big pharma company or they will be bought out, one of the two will happen if Neutrolin is as successful as expected. Management has made is very clear they are willing to partner, we know with their current financial situation and being a very small company they cannot successfully take Neutrolin to market alone. They only thing is either of the two will take a little while. If we get approved for NDA, a partnership will probably follow but a buyout will be after FDA approval which will likely come in 1st quarter 2020. They said in one of the conference calls, and its listed on their website that if they get FDA approval they will be ready to hit the market the second half of next year.

A buyout will be good but it all depends on the price action. Companies usually pay a premium for the businesses they want to acquire. Most of the time 100% or more and the higher the price at the time of the buyout the higher the payout. Also if the share price spikes to lets say $50 then settled at $20 on FDA approval and someone held for a buyout but the buyout price is only $35. It all depends on your exit strategy and how many billions the are willing to pay

So would you sell prior to a buyout ?

 

[newarkhiphop]

So would you sell prior to a buyout ?

if I understood correctly yea you would want to sell right before a buyout?

 

[ORDER_66]

Congrats to yall boys!!!

It's still not higher than $9...

 

[ahomeplateslugger]

Congrats to yall boys!!!

not done yet. need this to go higher. 1 year price target is around $20 from what i remember.

 

[ORDER_66]

not done yet. need this to go higher. 1 year price target is around $20 from what i remember.

That's a good look, and what I hear too from a few conversations on yahoo finance... I'm gonna buy into this and the female viagra $PTN when I get a chance..